TotalMarketCap

Scynexis

SCYXNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$33.082 M

$3.33 -13.41%

Close of 6 Nov 2026

As of 6 Nov 2026, Scynexis (SCYX) has a market capitalization of $33.1M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$20.6M

#2961 by revenue

Earnings

-$8.61M

Loss-making

Shares outstanding

9,953,155

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #357GridAI TechnologiesGRDX$33.9M
  2. #358Nasus PharmaNSRX$33.8M
  3. #359ScynexisSCYX$33.1M
  4. #360NanoviricidesNNVC$32.9M
  5. #361ProMIS NeurosciencesPMN$31.7M

What if Scynexis were worth as much as…

Open the what-if tool →

Gold $28.2T

$2,837,988

Per share 853,530× higher

Bitcoin $1.53T

$153,558.60

Per share 46,183× higher

Apple $5.02T

$504,118.56

Per share 151,615× higher

Or at a round number

$50.0M$100.0M$200.0M$500.0M

Where these numbers come from

Share counts and financials for Scynexis are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.